Grant of Options

RNS Number : 4166A

Allergy Therapeutics PLC

30 March 2012

 



30 March 2012

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

Grant of Options

Allergy Therapeutics plc (AIM: AGY) announces that, pursuant to the Allergy Therapeutics plc Long Term Share Incentive Plan ('LTIP'), on 30 March 2012 provisional shares of 0.1 pence each in the share capital of the Company were awarded to the following Board Directors, Mr Manuel Llobet (Chief Executive Officer) and Mr Ian Postlethwaite (Finance Director) at nil cost, as follows:

Director	Number of provisional shares awarded	Date of distribution	Total provisional shares held under LTIPs
Manuel Llobet	720,000	30 March 2012	2,190,000
Ian Postlethwaite	360,000	30 March 2012	1,320,000

The distribution of these ordinary shares of 0.1 pence each under the LTIP is conditional on the Company's performance over the course of the next three years.

-Ends-

For further information

Allergy Therapeutics	[phone]
Manuel Llobet, Chief Executive Officer
Nomura Code Securities	[phone]
Juliet Thompson/ Clare Terlouw

 

END

 

 

RDSGGGDXGBXBGDG